Cite

HARVARD Citation

    Bonelli, M. et al. (n.d.). Abatacept (CTLA‐4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis. Arthritis and rheumatism. 65 (3), pp. 599-607. [Online]. 
  
Back to record